ERNA vs IBM · P/E 0.0, rev $582.0K vs P/E 25, rev $67.53B
Eterna Therapeutics Inc (ERNA) versus International Business Machines (IBM) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported IBM revenue for 2025-12-31 was $67.53B. Net income was $10.59B. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Not investment advice. Open the ERNA and IBM stock pages for the full models.
Not investment advice.